{"id":45634,"date":"2022-06-29T14:02:11","date_gmt":"2022-06-29T12:02:11","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/gsk-selects-target-the-future-grant-recipient-in-innovation-challenge-supporting-multiple-myeloma-community\/"},"modified":"2022-06-29T14:02:11","modified_gmt":"2022-06-29T12:02:11","slug":"gsk-selects-target-the-future-grant-recipient-in-innovation-challenge-supporting-multiple-myeloma-community","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/gsk-selects-target-the-future-grant-recipient-in-innovation-challenge-supporting-multiple-myeloma-community\/","title":{"rendered":"GSK Selects Target the Future Grant Recipient in Innovation Challenge Supporting Multiple Myeloma Community"},"content":{"rendered":"
\n

\nInaugural grant awarded to the HealthTree Foundation, a pioneering non-profit organization whose proposal will address disparities in care in multiple myeloma\n<\/p>\n

<\/a><\/p>\n

PHILADELPHIA–(BUSINESS WIRE)–#Diversity<\/a>–GSK plc today announced the first recipient of the Target the Future<\/a> Think Tank Challenge \u00a370,000 (equivalent to approximately $100,000) grant to the HealthTree Foundation<\/a>, a non-profit organization helping patients learn more about their health and become their own best advocates. Their proposal, the \u201cHealthTree Equity and Diversity for Multiple Myeloma Program,\u201d will improve access, education and support for underserved communities and minority patients.\n<\/p>\n

\nTania Small, Vice President, Global Head of Oncology Medical Affairs and Head of R&D Diversity, Equity and Inclusion at GSK,<\/b> said: \u201cThe response to this challenge showcased an abundance of innovation, creativity and ingenuity, which we need to address patients\u2019 unmet needs. We see great potential in the HealthTree Foundation\u2019s proposal, which goes beyond the science to improve access, equitable care and quality of life for the multiple myeloma community.\u201d\n<\/p>\n

\nGSK\u2019s grant will help support the HealthTree Foundation as it develops digital delivery tools to distribute information on treatments and trials, facilitate digital communities and expand outreach efforts to support, educate and provide more equitable care to multiple myeloma patients.\n<\/p>\n

\nJenny Ahlstrom, Founder and CEO of the HealthTree Foundation, <\/b>said: \u201cI am alive today because I had the right information and treatments, and we must extend that access to communities of color. GSK saw problems and created a program to target a better future. Because of GSK\u2019s support, we can implement a strategy to help our community by providing necessary tools to broaden awareness. We\u2019re ready to make a difference in this underserved population suffering from multiple myeloma.\u201d\n<\/p>\n

\nSpecifically, the Target the Future grant from GSK will aid in the expansion of two of the following initiatives at the HealthTree Foundation:\n<\/p>\n